Helicobacter pylori lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells  by Teshima, Shigetada et al.
Helicobacter pylori lipopolysaccharide enhances the expression of
NADPH oxidase components in cultured guinea pig gastric mucosal cells
Shigetada Teshimaa, Shohko Tsunawakib, Kazuhito Rokutana;*
aDepartment of Nutrition, School of Medicine, The University of Tokushima, 3-18-15 Kuramoto-cho, Tokushima City, Tokushima 770-8503, Japan
bThe National Children’s Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo 154-8509, Japan
Received 24 March 1999; received in revised form 23 April 1999
Abstract Recently, we showed that cultured guinea pig gastric
pit cells possess a phagocyte NADPH oxidase-like activity,
which was up-regulated by Helicobacter pylori lipopolysaccha-
ride. We demonstrate here that these cells express all of the
phagocyte NADPH oxidase components (gp91-, p22-, p67-,
p47-, and p40-phoxes). Treatment with lipopolysaccharide
increased the expression of gp91-, p22-, and p67-phoxes, but
not that of p47- and p40-phoxes. Intriguingly, the p67-phox
expression consistently correlated with up-regulation of super-
oxide anion-producing ability. Thus, the gastric pit cell NADPH
oxidase may play an important role in regulation of the
inflammatory response associated with H. pylori infection.
z 1999 Federation of European Biochemical Societies.
Key words: NADPH oxidase; Superoxide anion;
Lipopolysaccharide; Gastric mucosal cell ; Helicobacter pylori
1. Introduction
Helicobacter pylori is now recognized as a crucial pathogen
for chronic gastritis type B and peptic ulcer, and as a possible
contributor to the development of adenocarcinoma of the
stomach [1,2]. H. pylori ¢rst comes into contact with gastric
pit cells. Our e¡orts to ¢nd the signal molecules which regu-
late the interactions between this Gram-negative bacterium
and gastric pit cells revealed that primary cultures of guinea
pig gastric pit cells secrete an abundant amount of superoxide
anion through the NADPH oxidase-like system [3]. In addi-
tion, H. pylori lipopolysaccharide (LPS) potentiated the cells
for enhanced capacity of O32 generation, resulting in the acti-
vation of nuclear factor UB in an autoregulatory manner [3].
With regard to modulation of in£ammation and immune
responses, including pyrogenicity, B-cell mitogenicity [4], and
activation of endothelial cells [5], H. pylori LPS has been
considered to be less active than LPS derived from Entero-
bacteriaceae, such as Escherichia coli. The concentration of H.
pylori LPS required for the priming of phagocytic cells is
1000^10 000-fold higher than that of E. coli LPS [6]. However,
recently, H. pylori LPS was shown to induce atrophic gastritis
[7] and modulate the functions of several types of gastric
mucosal cells, such as stimulation of pepsinogen release by
guinea pig gastric chief cells [8], histamine secretion from rat
enterochroma⁄n-like cells [9], and apoptosis of rat gastric
surface mucous cells [10].
Phagocyte NADPH oxidase is a complex electron transport
chain, which is switched to transfer a single electron from
NADPH to molecular oxygen to form O32 upon cell stimula-
tion. The NADPH oxidase consists of membrane-bound cy-
tochrome b558 heterodimer (gp91-phox and p22-phox) and
four cytosolic components (p67-phox, p47-phox, and p40-
phox), and is modulated by p21 Rac1/2 (see [11] for a review).
In a previous report [3], we found the interesting phenomenon
that unstimulated gastric pit cells possess a membrane-associ-
ated NADPH oxidase activity, which is negligible in resting
phagocytes. They also contained p47-phox and p67-phox pro-
teins in the cytoplasm, suggesting that the O32 -generating sys-
tem in gastric pit cells may share functional and structural
features with that of phagocytes. However, the precise molec-
ular characterization of the pit cell oxidase has not been done.
In this study, we further characterized the gastric pit cell
NADPH oxidase system by examining the expression of all
the phox components by immunoblot analysis and the subcel-
lular localization of p47- and p67-phoxes by confocal laser
microscopy. Furthermore, we demonstrated that H. pylori
LPS signi¢cantly increased the amounts of p67-, p22-, and
gp91-phoxes, but not p47- and p40-phoxes, in the cells in
association with the up-regulation of O32 release.
2. Materials and methods
2.1. Reagents and media
H. pylori (NCTC 11637) was kindly provided by Dr. Nakazawa
(University of Yamaguchi, Japan). An enhanced chemiluminescence
Western blotting detection system and Fluorolink Cy3-labelled goat
anti-rabbit IgG were purchased from Amersham Japan (Tokyo). LPS
from E. coli K-235, superoxide dismutase (SOD, from horse heart),
ferricytochrome c, vancomycin, and amphotericin B were purchased
from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Preparation of H. pylori LPS
H. pylori (NCTC 11637) was cultured in 10 ml of brucella broth
(Gibco, Grand Island, NY, USA), supplemented with 5% (v/v) FCS,
10 Wg/ml vancomycin, and 2 Wg/ml amphotericin B, for 48 h at 37‡C
under microaerobic conditions (12% CO2-5% O2-83% N2). The via-
bility and shape of the organisms were monitored by phase-contrast
microscope. H. pylori LPS was prepared by the hot-phenol water
method as previously reported [3]. All procedures were performed
with the approval of the respective institutional biosafety review com-
mittees and in compliance with their guidelines for biohazards.
2.3. Preparation and culture of gastric mucosal cells
Male guinea pigs weighing approximately 250 g were purchased
from Shizuoka Laboratory Animal Center Inc. (Shizuoka, Japan).
Gastric mucosal cells were isolated aseptically from guinea pig fundic
glands and cultured, as described previously [12,13]. The cultured cells
were characterized by cytochemical and immunocytochemical analyses
as well as transmission electron microscopic examination [3,13]. The
cultured cells consisted of pit cells (about 90%), parietal cells (5%),
mucous neck cells (less than 1%), ¢broblasts (less than 1%), and
granule-free progenitor cells (5%) [3]. Among these cells populations,
only matured pit cells expressed detectable levels of p47- and p67-
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phoxes [3]. These cells were identi¢ed as the cells responsible for O32
production by nitroblue tetrazolium staining [3].
2.4. Preparation of guinea pig peritoneal neutrophils
Guinea pig peritoneal neutrophils were obtained by £ushing peri-
toneal cavities with saline 12 h after an intraperitoneal injection of 25
ml of 3% thioglycolate broth as described previously [3]. Microscopic
observation after Giemsa staining revealed that more than 90% of
peritoneal exudated cells were neutrophils.
2.5. Measurement of O32 release from gastric mucosal cells
O32 release from gastric mucosal cells was measured as the SOD-
inhibitable reduction of ferricytochrome c as described previously [3].
The reduction of ferricytochrome c was spectrophotometrically deter-
mined at 550 nm, and the amount of O32 release was expressed as
nmol/mg protein/h. Cell protein was determined by the method of
Lowry et al. using bovine serum albumin as a standard.
2.6. Immunoblot analysis
Antisera against the human NADPH oxidase components were
raised in rabbits by injection of keyhole limpet hemocyanin-conju-
gated synthetic peptides corresponding to gp91-phox (residues 536^
555), p22-phox (residues 177^195), p47-phox (residues 376^390), and
p40-phox (residues 1^15), as described previously [14,15]. Polyclonal
antibodies against recombinant human p47-phox and human p67-
phox were gifts from Dr. Babior (The Scripps Research Institute,
California, USA). Whole-cell extracts were prepared from gastric mu-
cosal cells or neutrophils, as described previously [3]. The whole-cell
proteins (50 Wg of protein per lane) were then separated by SDS-
PAGE in a 10% polyacrylamide gel and transferred to a polyvinyl-
idene di£uoride ¢lter. The ¢lter was blocked with 4% puri¢ed milk
casein for 30 min at room temperature and then incubated for 1 h
with each of the above antibody at a dilution of 1:1000. After wash-
ing with phosphate-bu¡ered saline (PBS) containing 0.1% (v/v) Tween
20, reacted antibodies were revealed by an enhanced chemilumines-
cence Western blotting detection system.
2.7. Confocal microscopic analysis
Untreated cells were ¢xed in 3% paraformaldehyde in PBS for 20
min. After washing with PBS, the cells were permeabilized with 0.01%
(v/v) Triton X-100 for 30 s, and then incubated in 4% (v/v) milk casein
for 30 min. After washing, the cells were incubated with 50 times
diluted antibody against either p67- or p47-phox for 1 h at room
temperature. Immuno-reacted antibodies were detected with £uores-
cein (rhodamine)-linked anti-rabbit IgG. Subcellular localization of
either p67- or p47-phox was imaged by confocal laser scanning
microscopy (Vex = 550 nm and Vem = 570 nm) (Leica TCS NT, Heidel-
berg, Germany).
3. Results
3.1. Expression of the phagocyte NADPH oxidase components
in gastric mucosal cells
Before analyzing the expression of gp91-, p22-, p67-, p47-,
and p40-phoxes by immunoblotting with antibodies against
human phox proteins in guinea pig gastric mucosal cells, we
tested whether each antibody could speci¢cally recognize the
respective phox protein of guinea pig neutrophils. As shown in
Fig. 1, all phox proteins in guinea pig neutrophils were de-
tected by the anti-human phox antibodies. The molecular
mass of gp91-phox, p67-phox, p47-phox, p40-phox, or p22-
phox in neutrophils was determined to be 54^60 kDa [16],
63 kDa [17], 47 kDa [17], 39 kDa [17], or 22 kDa [16], re-
spectively, being consistent with those in macrophages. The
di¡erence between human (91 kDa) and guinea pig (54^60
kDa) in the molecular mass of gp91-phox is attributed to
the degree of glycosylation [16].
Gastric mucosal cells contained immunoreactive proteins
corresponding to all of the phox proteins; however, they ex-
pressed gp91- and p40-phoxes at much lower levels than neu-
trophils (Fig. 1). The molecular mass of guinea pig neutrophil
p67-phox is known to be 63 kDa, but gastric mucosal cells
contained an immunoreactive protein with a molecular mass
of 67 kDa. This intriguing 67 kDa protein was further con-
¢rmed to be p67-phox by immunoblotting with two distinct
antibodies against human p67-phox [18] and porcine p63-phox
[19] (data not shown).
Subcellular localization of p67- or p47-phox in resting gas-
tric pit cells was analyzed by confocal laser scanning micros-
copy after immuno£uorescence staining (Fig. 2). Signi¢cant
amounts of p67-phox were localized along the plasma mem-
brane, as well as in the cytoplasm (Fig. 2B). A small amount
of p47-phox was also seen in the peripheral membrane region,
while it was mainly distributed in the cytosol (Fig. 2D). It is
known that translocated p47-phox to the plasma membrane
anchors p67-phox for the activation of the phagocyte
NADPH oxidase [15]. Thus, this unique translocation pro¢le
of p67- and p47-phoxes in a resting state may explain sponta-
neous O32 release from gastric pit cells.
3.2. E¡ect of LPS from H. pylori or E. coli on expression of
NADPH oxidase components
Untreated gastric mucosal cells released 53 þ 4 nmol O32 /mg
protein/h (mean þ S.D., n = 12). Their treatment with H. pylori
LPS (0.5 ng/ml) or E. coli LPS (10 ng/ml) for 12 h signi¢cantly
increased O32 release to 153 þ 9 (n = 12) or 161 þ 12 nmol O
3
2 /
mg protein/h (n = 12), respectively. The e¡ect of a protein syn-
thesis inhibitor, cycloheximide, on each LPS-primed O32 re-
lease was examined. Cycloheximide at 100 ng/ml did not
change the basal amount of O32 production (52 þ 4 nmol
O32 /mg protein/h, n = 12). However, it completely inhibited
Fig. 1. Expression of neutrophil NADPH oxidase components in
gastric mucosal cells. Whole-cell proteins were prepared from neu-
trophils or gastric mucosal cells as described in Section 2. Samples
(50 Wg protein per lane) were separated by SDS-PAGE in a 10%
acrylamide gel and transferred to a polyvinylidene di£uoride ¢lter.
Immunoblot analysis with antibodies against each phox protein was
performed as described in Section 2. Molecular masses, indicated by
arrows, were calculated from the positions of the molecular mass
standards (MWSTD, Bio-Rad) shown on the right.
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the primed increases in O32 production by H. pylori or E. coli
LPS, leaving them at the basal levels : 56 þ 9 (n = 12) for H.
pylori LPS and 59 þ 8 nmol O32 /mg protein/h (n = 12) for E.
coli LPS. These results suggest that the LPSs induced certain
phox proteins for the enhanced capacity of O32 release. Cells
stayed viable throughout the experiments, based on continued
trypan blue exclusion, adherence to the culture plates, and
unchanged morphological features (data not shown).
To elucidate the cellular events leading to the priming of
O32 release with the LPSs, we compared the expression of the
NADPH oxidase components before and after treatment (Fig.
3). In response to H. pylori LPS (Fig. 3A,B) or E. coli LPS
(Fig. 3D,E), gp91- and p22-phoxes were somewhat induced
(Fig. 3C,F), while the expression of p47- and p40-phoxes
was not changed (data not shown). Of phox components,
the expression of p67-phox consistently correlated with up-
regulation of O32 -producing ability (Fig. 3C,F) with both
LPSs. Thus, p67-phox is likely to be a key molecule to regu-
late the O32 -producing capacity of gastric pit cells, as shown in
the HL-60 cell line [33].
4. Discussion
In our previous study [3], cell-free reconstitution experi-
ments and immunoblot analysis with antibodies against p47-
and p67-phoxes suggested that gastric pit cells in culture have
a phagocyte NADPH oxidase-like enzyme. However, the pres-
ence of other critical components of the phagocyte oxidase,
particularly a redox center of cytochrome b558, had not been
determined. Cultured gastric pit cells can spontaneously se-
crete a larger amount of O32 (1.08 nmol/10
6 cells/min) than
murine resident peritoneal macrophages stimulated by phor-
bol diester (0.07 nmol/106 cells/min), and their oxidase activity
was markedly sensitive to H. pylori LPS. These features have
not been documented in any cell types including phagocytes,
implying that the pit cells have a unique NADPH oxidase
system.
To address these issues, we examined the expression of
gp91-, p22-, p67-, p47-, and p40-phoxes, using speci¢c anti-
bodies against the human neutrophil phox components. To
our knowledge, this is the ¢rst report that gastric mucosal
cells express all of these essential components of the neutro-
phil NADPH oxidase. Several non-phagocytic cells, including
¢broblasts [20], endothelial cells [21], and glomerular mesan-
gial cells [22], are known to produce low levels of O32 (less
than 0.2 nmol/106 cells/min). Among the phox components,
p22-, p47-, and p67-phoxes are ubiquitously expressed in non-
phagocytic cells [20^22]. However, the expression of gp91-
phox has not been documented. Lower O32 -generating activ-
ities in those cells are suggested to be due to the lack of this
component [20^22]. The present ¢nding that gastric mucosal
cells expressed a detectable level of gp91-phox may explain
their unexpectedly higher capacity for O32 production, com-
pared to the above non-phagocytic cells.
The p40-phox expression in gastric mucosal cells was at an
extremely lower level in contrast to that in neutrophils (Fig.
1). Neutrophil NADPH oxidase activity can be reconstituted
in a cell-free system in the absence of p40-phox [23]. p40-phox
that interacts with p67-phox is proposed to inhibit transloca-
tion of p67-phox to plasma membrane in resting neutrophils
[15], being a negative regulator of the NADPH oxidase, rather
than an essential component for O32 production. Thus, the
gastric pit cell oxidase may be constitutively active because
Fig. 2. Subcellular localization of p67- and p47-phoxes. Unstimu-
lated resting gastric pit cells were immuno£uorescently stained with
antibody against either p67-phox (B) or p47-phox (D), as described
in Section 2. Cells were examined by phase contrast (A and C) or
by confocal laser scanning microscopy (B and D).
Fig. 3. E¡ect of H. pylori LPS or E. coli LPS on the levels of
NADPH oxidase components. Cells were treated with 0.5 ng/ml of
H. pylori LPS (A^C) or 10 ng/ml of E. coli LPS (D^F) for the indi-
cated times. Whole-cell proteins were extracted and immunoblot
analyses were performed, as described in the legend to Fig. 1. Un-
treated control cells are indicated as ‘c’. The levels of phox proteins
(p67-phox [F], gp91-phox [R], and p22-phox [b]) were quanti¢ed by
densitometry and standardized by the levels of respective proteins in
untreated control cells. Values are mean þ S.D. in three separate ex-
periments. Representative results are shown in A and D. The
amounts of O32 release were measured as described in Section 2,
and the results are expressed as nmol O32 /mg protein/h (C and F).
Values are mean þ S.D., n = 10.
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of the insu⁄ciency of the negative regulation by p40-phox,
resulting in spontaneous secretion of O32 . At present, there
is no evidence that directly veri¢es this concept, but this might
be supported by the ¢nding that signi¢cant amounts of p67-
phox were detected on the plasma membrane of resting gastric
pit cells (Fig. 2).
The kinetics of E. coli LPS-induced up-regulation of O32
production by gastric mucosal cells resembles that of the mac-
rophage NADPH oxidase [24,25]. In the latter case, the prim-
ing appeared 8 h after exposure to E. coli LPS and required
de novo synthesis of proteins, including the NADPH oxidase
components [26^28]. The priming of gastric mucosal cells was
more sensitive to H. pylori LPS than E. coli LPS and also
associated with de novo protein synthesis as demonstrated
by cycloheximide experiments. Cycloheximide completely
blocked the LPS-induced increase in O32 release, but did not
a¡ect the basic one. Among the phox components examined,
the magnitude and time course of the increase in p67-phox
coincided with those of up-regulation of O32 production
with H. pylori LPS or E. coli LPS. p67-phox has been consid-
ered to be one of the critical components to regulate the
activity of phagocyte NADPH oxidase [29]. In addition, the
expression of gp91- and p22-phoxes was also up-regulated by
each LPS to a small degree. These observations suggest that
the regulation of phox proteins, particularly p67-phox, with
each LPS may be a critical step to control the O32 -producing
ability of gastric pit cells. Therefore, it would be important to
reveal LPS-mediated intracellular signals that up-regulate
these components.
Gastric pit cells were reported to phagocytose neighboring
dead cells [30], express MHC class II antigen with H. pylori
infection [31,32], and produce abundant O32 speci¢cally in
response to bacterial LPSs, all functions which resemble those
of macrophages. Our results support the concept that gastric
pit cells are the ¢rst line of defense against H. pylori infection.
They may actively bear in£ammatory and immune responses
of gastric mucosa through the unique NADPH oxidase.
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